{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:34:34Z","timestamp":1792726474241,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00722-0","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:14:48Z","timestamp":1764731688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring therapeutic targets for cryptococcosis: in silico and in vitro testing for isocitrate lyase (ICL1) potential inhibitors"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-7544","authenticated-orcid":false,"given":"Gabriel","family":"Xavier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliete Costa","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Santos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Helena Marques","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2397-7119","authenticated-orcid":false,"given":"Andrei Santos","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"722_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/jof7040282","volume":"7","author":"C Firacative","year":"2021","unstructured":"Firacative C, Meyer W, Casta\u00f1eda E (2021) Cryptococcus neoformans and Cryptococcus Gattii species complexes in Latin America: a map of molecular types, genotypic diversity, and antifungal susceptibility as reported by the Latin American Cryptococcal study group. J Fungi 7:282. https:\/\/doi.org\/10.3390\/jof7040282","journal-title":"J Fungi"},{"key":"722_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ et al (2017) Global burden of disease of HIV-associated Cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873\u2013881. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8","journal-title":"Lancet Infect Dis"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"e170554","DOI":"10.1590\/0074-02760170554","volume":"113","author":"C Firacative","year":"2018","unstructured":"Firacative C, Lizarazo J, Illnait-Zaragoz\u00ed MT, Casta\u00f1eda E (2018) The status of cryptococcosis in Latin America. Mem Inst Oswaldo Cruz 113:e170554. https:\/\/doi.org\/10.1590\/0074-02760170554","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"722_CR4","doi-asserted-by":"publisher","first-page":"105521","DOI":"10.1016\/j.micpath.2022.105521","volume":"166","author":"SS Rathore","year":"2022","unstructured":"Rathore SS, Sathiyamoorthy J, Lalitha C, Ramakrishnan J (2022) A holistic review on Cryptococcus neoformans. Microb Pathog 166:105521. https:\/\/doi.org\/10.1016\/j.micpath.2022.105521","journal-title":"Microb Pathog"},{"key":"722_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/mmi.14565","volume":"114","author":"A Bermas","year":"2020","unstructured":"Bermas A, Geddes-McAlister J (2020) Combatting the evolution of antifungal resistance in Cryptococcus neoformans. Mol Microbiol 114:721\u2013734. https:\/\/doi.org\/10.1111\/mmi.14565","journal-title":"Mol Microbiol"},{"key":"722_CR6","doi-asserted-by":"publisher","unstructured":"Zhou Z, Zhu C, Ip M et al (2022) Molecular epidemiology and antifungal resistance of Cryptococcus neoformans from human immunodeficiency virus-negative and human immunodeficiency virus-positive patients in Eastern China. Front Microbiol 13:942940. https:\/\/doi.org\/10.3389\/fmicb.2022.942940","DOI":"10.3389\/fmicb.2022.942940"},{"key":"722_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR (2016) Cryptococcosis. Infect Dis Clin North Am 30:179\u2013206. https:\/\/doi.org\/10.1016\/j.idc.2015.10.006","journal-title":"Infect Dis Clin North Am"},{"key":"722_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/QCO.0000000000000458","volume":"31","author":"AF Henao-Mart\u00ednez","year":"2018","unstructured":"Henao-Mart\u00ednez AF, Chastain DB, Franco-Paredes C (2018) Treatment of cryptococcosis in non-HIV immunocompromised patients. Curr Opin Infect Dis 31:278\u2013285. https:\/\/doi.org\/10.1097\/QCO.0000000000000458","journal-title":"Curr Opin Infect Dis"},{"key":"722_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","volume":"19","author":"KR Iyer","year":"2021","unstructured":"Iyer KR, Revie NM, Fu C et al (2021) Treatment strategies for Cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 19:454\u2013466. https:\/\/doi.org\/10.1038\/s41579-021-00511-0","journal-title":"Nat Rev Microbiol"},{"key":"722_CR10","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tim.2017.10.002","volume":"26","author":"MC Van Caballero","year":"2018","unstructured":"Van Caballero MC, Wormley FL (2018) A call to arms: quest for a Cryptococcal vaccine. Trends Microbiol 26:436\u2013446. https:\/\/doi.org\/10.1016\/j.tim.2017.10.002","journal-title":"Trends Microbiol"},{"key":"722_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","volume":"14","author":"RC May","year":"2016","unstructured":"May RC, Stone NRH, Wiesner DL et al (2016) Cryptococcus: from environmental saprophyte to global pathogen. Nat Rev Microbiol 14:106\u2013117. https:\/\/doi.org\/10.1038\/nrmicro.2015.6","journal-title":"Nat Rev Microbiol"},{"key":"722_CR12","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1128\/IAI.70.10.5684-5694.2002","volume":"70","author":"TH Rude","year":"2002","unstructured":"Rude TH, Toffaletti DL, Cox GM, Perfect JR (2002) Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans. Infect Immun 70:5684\u20135694. https:\/\/doi.org\/10.1128\/IAI.70.10.5684-5694.2002","journal-title":"Infect Immun"},{"key":"722_CR13","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1099\/mic.0.030858-0","volume":"155","author":"MF Dunn","year":"2009","unstructured":"Dunn MF, Ram\u00edrez-Trujillo JA, Hern\u00e1ndez-Lucas I (2009) Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis. Microbiology 155:3166\u20133175. https:\/\/doi.org\/10.1099\/mic.0.030858-0","journal-title":"Microbiology"},{"key":"722_CR14","doi-asserted-by":"publisher","first-page":"12951","DOI":"10.3390\/cimb46110771","volume":"46","author":"MA Khan","year":"2024","unstructured":"Khan MA, Azam M, Younus H (2024) In silico and in vitro studies to explore the effect of thymoquinone on isocitrate Lyase, biofilm Formation, and the expression of some virulence genes in Candida albicans. Curr Issues Mol Biol 46:12951\u201312967. https:\/\/doi.org\/10.3390\/cimb46110771","journal-title":"Curr Issues Mol Biol"},{"key":"722_CR15","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1080\/07391102.2022.2038271","volume":"41","author":"KB Lokhande","year":"2023","unstructured":"Lokhande KB, Pawar SV, Madkaiker S et al (2023) High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of acinetobacter baumannii: anti-virulent drug development campaign. J Biomol Struct Dyn 41:2698\u20132712. https:\/\/doi.org\/10.1080\/07391102.2022.2038271","journal-title":"J Biomol Struct Dyn"},{"key":"722_CR16","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41598-023-28716-8","volume":"13","author":"D Pirolli","year":"2023","unstructured":"Pirolli D, Righino B, Camponeschi C et al (2023) Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein\/ACE2 interface. Sci Rep 13:1494. https:\/\/doi.org\/10.1038\/s41598-023-28716-8","journal-title":"Sci Rep"},{"key":"722_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-3441-7_1","volume":"2714","author":"A Talevi","year":"2024","unstructured":"Talevi A (2024) Computer-aided drug discovery and design: recent advances and future prospects. Methods Mol Biol Clifton NJ 2714:1\u201320. https:\/\/doi.org\/10.1007\/978-1-0716-3441-7_1","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"722_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ymeth.2022.02.004","volume":"203","author":"M Lazniewski","year":"2022","unstructured":"Lazniewski M, Dermawan D, Hidayat S et al (2022) Drug repurposing for identification of potential Spike inhibitors for SARS-CoV-2 using molecular Docking and molecular dynamics simulations. Methods San Diego Calif 203:498\u2013510. https:\/\/doi.org\/10.1016\/j.ymeth.2022.02.004","journal-title":"Methods San Diego Calif"},{"key":"722_CR19","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"722_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z et al (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"722_CR21","doi-asserted-by":"publisher","unstructured":"Teufel F, Almagro Armenteros JJ, Johansen AR et al (2022) SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol 40:1023\u20131025. https:\/\/doi.org\/10.1038\/s41587-021-01156-3","DOI":"10.1038\/s41587-021-01156-3"},{"key":"722_CR22","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis IW, Leaver-Fay A, Chen VB et al (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375\u2013W383. https:\/\/doi.org\/10.1093\/nar\/gkm216","journal-title":"Nucleic Acids Res"},{"key":"722_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s0076-6879(97)77022-8","volume":"277","author":"D Eisenberg","year":"1997","unstructured":"Eisenberg D, L\u00fcthy R, Bowie JU (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 277:396\u2013404. https:\/\/doi.org\/10.1016\/s0076-6879(97)77022-8","journal-title":"Methods Enzymol"},{"key":"722_CR24","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","volume":"36","author":"G Studer","year":"2020","unstructured":"Studer G, Rempfer C, Waterhouse AM et al (2020) QMEANDisCo-distance constraints applied on model quality estimation. Bioinforma Oxf Engl 36:1765\u20131771. https:\/\/doi.org\/10.1093\/bioinformatics\/btz828","journal-title":"Bioinforma Oxf Engl"},{"key":"722_CR25","doi-asserted-by":"publisher","first-page":"W448","DOI":"10.1093\/nar\/gkv306","volume":"43","author":"CM Labb\u00e9","year":"2015","unstructured":"Labb\u00e9 CM, Rey J, Lagorce D et al (2015) MTiOpenScreen: a web server for structure-based virtual screening. Nucleic Acids Res 43:W448\u2013W454. https:\/\/doi.org\/10.1093\/nar\/gkv306","journal-title":"Nucleic Acids Res"},{"key":"722_CR26","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K et al (2023) AmberTools. J Chem Inf Model 63:6183\u20136191. https:\/\/doi.org\/10.1021\/acs.jcim.3c01153","journal-title":"J Chem Inf Model"},{"key":"722_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the amber biomolecular simulation package. WIREs Comput Mol Sci 3:198\u2013210. https:\/\/doi.org\/10.1002\/wcms.1121","journal-title":"WIREs Comput Mol Sci"},{"key":"722_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW et al (2004) Development and testing of a general amber force field. J Comput Chem 25:1157\u20131174. https:\/\/doi.org\/10.1002\/jcc.20035","journal-title":"J Comput Chem"},{"key":"722_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA et al (2020) ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16:528\u2013552. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591","journal-title":"J Chem Theory Comput"},{"key":"722_CR30","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gks375","volume":"40","author":"R Anandakrishnan","year":"2012","unstructured":"Anandakrishnan R, Aguilar B, Onufriev AV (2012) H\u2009+\u2009+\u20093.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res 40:W537\u2013541. https:\/\/doi.org\/10.1093\/nar\/gks375","journal-title":"Nucleic Acids Res"},{"key":"722_CR31","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1021\/jz501780a","volume":"5","author":"S Izadi","year":"2014","unstructured":"Izadi S, Anandakrishnan R, Onufriev AV (2014) Building water models: a different approach. J Phys Chem Lett 5:3863\u20133871. https:\/\/doi.org\/10.1021\/jz501780a","journal-title":"J Phys Chem Lett"},{"key":"722_CR32","doi-asserted-by":"publisher","unstructured":"Wang C, Greene D, Xiao L et al (2017) Recent developments and applications of the MMPBSA method. Front Mol Biosci 4:87. https:\/\/doi.org\/10.3389\/fmolb.2017.00087","DOI":"10.3389\/fmolb.2017.00087"},{"key":"722_CR33","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/ci600406v","volume":"47","author":"M Na\u00efm","year":"2007","unstructured":"Na\u00efm M, Bhat S, Rankin KN et al (2007) Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space. J Chem Inf Model 47:122\u2013133. https:\/\/doi.org\/10.1021\/ci600406v","journal-title":"J Chem Inf Model"},{"key":"722_CR34","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.xpro.2023.102512","volume":"4","author":"VL Barnes","year":"2023","unstructured":"Barnes VL, Heithoff DM, Mahan SP et al (2023) Antimicrobial susceptibility testing to evaluate minimum inhibitory concentration values of clinically relevant antibiotics. STAR Protoc 4:102512. https:\/\/doi.org\/10.1016\/j.xpro.2023.102512","journal-title":"STAR Protoc"},{"key":"722_CR35","doi-asserted-by":"publisher","unstructured":"Gillespie SH (1994) Antimicrobial susceptibility. Medical microbiology illustrated. Oxford, Eng. Boston, Mass: Butterworth Heinmann. Elsevier, pp 234\u2013247 https:\/\/doi.org\/10.1016\/B978-0-7506-0187-0.50025-0","DOI":"10.1016\/B978-0-7506-0187-0.50025-0"},{"key":"722_CR36","volume-title":"Reference method for broth Dilution antifungal susceptibility testing of yeats: approved standard","author":"CLSI","year":"2008","unstructured":"CLSI (2008) Reference method for broth Dilution antifungal susceptibility testing of yeats: approved standard, 3 edn. CLSI, Wayne, Pa","edition":"3"},{"key":"722_CR37","volume-title":"Reference method for broth Dilution antifungal susceptibility testing of yeasts: third informational supplement","author":"JH Rex","year":"2008","unstructured":"Rex JH (2008) Reference method for broth Dilution antifungal susceptibility testing of yeasts: third informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"722_CR38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jsb.2016.03.019","volume":"194","author":"Y Park","year":"2016","unstructured":"Park Y, Cho Y, Lee Y-H et al (2016) Crystal structure and functional analysis of isocitrate lyases from Magnaporthe oryzae and fusarium graminearum. J Struct Biol 194:395\u2013403. https:\/\/doi.org\/10.1016\/j.jsb.2016.03.019","journal-title":"J Struct Biol"},{"key":"722_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0969-2126(00)00117-9","volume":"8","author":"K Britton","year":"2000","unstructured":"Britton K, Langridge S, Baker P et al (2000) The crystal structure and active site location of isocitrate lyase from the fungus Aspergillus Nidulans. Structure 8:349\u2013362. https:\/\/doi.org\/10.1016\/S0969-2126(00)00117-9","journal-title":"Structure"},{"key":"722_CR40","doi-asserted-by":"publisher","unstructured":"Lee Y-V, Wahab HA, Choong YS (2015) Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and Non-M. tuberculosis: a summary. BioMed Res Int 2015:895453. https:\/\/doi.org\/10.1155\/2015\/895453","DOI":"10.1155\/2015\/895453"},{"key":"722_CR41","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1016\/j.bmcl.2012.03.047","volume":"22","author":"D Shingnapurkar","year":"2012","unstructured":"Shingnapurkar D, Dandawate P, Anson CE et al (2012) Synthesis and characterization of pyruvate\u2013isoniazid analogs and their copper complexes as potential ICL inhibitors. Bioorg Med Chem Lett 22:3172\u20133176. https:\/\/doi.org\/10.1016\/j.bmcl.2012.03.047","journal-title":"Bioorg Med Chem Lett"},{"key":"722_CR42","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/molecules27082447","volume":"27","author":"C Duan","year":"2022","unstructured":"Duan C, Jiang Q, Jiang X et al (2022) Discovery of a novel inhibitor structure of Mycobacterium tuberculosis isocitrate lyase. Molecules 27:2447. https:\/\/doi.org\/10.3390\/molecules27082447","journal-title":"Molecules"},{"key":"722_CR43","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1038\/ncomms5306","volume":"5","author":"M Nandakumar","year":"2014","unstructured":"Nandakumar M, Nathan C, Rhee KY (2014) Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat Commun 5:4306. https:\/\/doi.org\/10.1038\/ncomms5306","journal-title":"Nat Commun"},{"key":"722_CR44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1139\/cjm-2015-0230","volume":"61","author":"RDA Cordeiro","year":"2015","unstructured":"Cordeiro RDA, Serpa R, Marques FJDF et al (2015) Inhibitory activity of Isoniazid and ethionamide against Cryptococcus biofilms. Can J Microbiol 61:827\u2013836. https:\/\/doi.org\/10.1139\/cjm-2015-0230","journal-title":"Can J Microbiol"},{"key":"722_CR45","doi-asserted-by":"publisher","first-page":"175776","DOI":"10.1016\/j.ejphar.2023.175776","volume":"951","author":"HS Althagafy","year":"2023","unstructured":"Althagafy HS, El-Aziz MKA, Ibrahim IM et al (2023) Pharmacological updates of nifuroxazide: promising preclinical effects and the underlying molecular mechanisms. Eur J Pharmacol 951:175776. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175776","journal-title":"Eur J Pharmacol"},{"key":"722_CR46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ph11020054","volume":"11","author":"D Olender","year":"2018","unstructured":"Olender D, \u017bwawiak J, Zaprutko L (2018) Multidirectional efficacy of biologically active nitro compounds included in medicines. Pharmaceuticals 11:54. https:\/\/doi.org\/10.3390\/ph11020054","journal-title":"Pharmaceuticals"},{"key":"722_CR47","doi-asserted-by":"publisher","first-page":"25298","DOI":"10.1038\/srep25298","volume":"6","author":"Q Xiao","year":"2016","unstructured":"Xiao Q, Dong N, Yao X et al (2016) Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H. Sci Rep 6:25298. https:\/\/doi.org\/10.1038\/srep25298","journal-title":"Sci Rep"},{"key":"722_CR48","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2023) Method for the determination of broth Dilution minimum. Inhibitory concentrations of antifungal agents for yeasts"},{"key":"722_CR49","unstructured":"Alexander BD (2017) Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th edition. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"722_CR50","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijantimicag.2009.04.009","volume":"34","author":"R Cordeiro","year":"2009","unstructured":"Cordeiro R, de Brilhante A, Rocha RSN MFG, et al (2009) In vitro synergistic effects of antituberculous drugs plus antifungals against coccidioides posadasii. Int J Antimicrob Agents 34:278\u2013280. https:\/\/doi.org\/10.1016\/j.ijantimicag.2009.04.009","journal-title":"Int J Antimicrob Agents"},{"key":"722_CR51","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1128\/AAC.01471-10","volume":"55","author":"R Cordeiro","year":"2011","unstructured":"Cordeiro R, de Marques A, de Brilhante FJ RSN, et al (2011) Synergistic effect of antituberculosis drugs and Azoles in vitro against Histoplasma capsulatum var. capsulatum\u25bf. Antimicrob Agents Chemother 55:4482\u20134484. https:\/\/doi.org\/10.1128\/AAC.01471-10","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00722-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00722-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T03:14:50Z","timestamp":1764731690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00722-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00722-0","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"10"}}